JHS Svendgaard Laboratories receives substantial acquisition disclosure under SEBI takeover code

M&A / JV 30 Jun 2026 · Announced· ✓ Verified

JHS Svendgaard Laboratories Limited filed a Regulation 31(4) disclosure with NSE, indicating a substantial acquisition of shares. Under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, any acquisition crossing 5% of voting capital or moving from one slab to another triggers mandatory disclosure. The filing suggests an acquirer has breached a disclosure threshold and must now comply with public announcement and open offer requirements unless an exemption applies.

Why it mattersA substantial shareholder has crossed a disclosure threshold under the SEBI Takeover Code; the acquirer must now file a detailed public announcement within prescribed timelines, and the target board must convene to assess potential open offer obligations or exemptions.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals